...
首页> 外文期刊>Vascular pharmacology >Beta-adrenoceptor-mediated vasodilation of retinal blood vessels is reduced in streptozotocin-induced diabetic rats.
【24h】

Beta-adrenoceptor-mediated vasodilation of retinal blood vessels is reduced in streptozotocin-induced diabetic rats.

机译:在链脲佐菌素诱导的糖尿病大鼠中,β-肾上腺素受体介导的视网膜血管舒张减少。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We investigated the effects of epinephrine and dopamine on retinal blood vessels in streptozotocin (STZ, 80 mg/kg, i.p.)-treated rats and age-matched control rats to determine whether diabetes mellitus alters the retinal vascular responses to circulating catecholamines. Experiments were performed 6-8 weeks after treatment with STZ or the vehicle. The fundus images were captured with the digital fundus camera system for small animals we developed and diameters of retinal blood vessels contained in the digital images were measured. Epinephrine increased the diameters of retinal blood vessels, but the vasodilator responses were reduced in diabetic rats. Dopamine produced a biphasic retinal vascular response with an initial vasoconstriction followed by a vasodilation. The vasoconstrictor effects of dopamine on retinal arterioles were enhanced in diabetic rats, whereas the difference between the two groups was abolished by treatment with propranolol. The vasodilator effect of isoproterenol, but not of the activator of adenylyl cyclase colforsin, on retinal blood vessels was reduced in diabetic rats. No difference in vasoconstriction of retinal blood vessels to phenylephrine between non-diabetic and diabetic rats was observed. The vasodilator responses of retinal blood vessels to 1,1-dimethyl-4-phenylpiperazinium, a ganglionic nicotinic receptor agonist, were also attenuated in diabetic rats. These results suggest that diabetes mellitus alters the retinal vascular responses to circulating catecholamines and the impairment of vasodilator responses mediated by beta-adrenoceptors contributes to the alteration.
机译:我们研究了肾上腺素和多巴胺对链脲佐菌素(STZ,80 mg / kg,i.p.)处理的大鼠和年龄匹配的对照组大鼠视网膜血管的影响,以确定糖尿病是否改变了视网膜对循环儿茶酚胺的血管反应。用STZ或媒介物治疗后6-8周进行实验。用我们开发的小型动物的数字眼底照相机系统捕获眼底图像,并测量数字图像中包含的视网膜血管直径。肾上腺素增加了视网膜血管的直径,但在糖尿病大鼠中血管舒张反应减少。多巴胺产生了双相性视网膜血管反应,最初是血管收缩,随后是血管扩张。在糖尿病大鼠中,多巴胺对视网膜小动脉的血管收缩作用增强,而普萘洛尔治疗可消除两组之间的差异。在糖尿病大鼠中,异丙肾上腺素对视网膜血管的血管舒张作用减弱,但腺苷酸环化酶科尔福素的活化剂未见舒张作用。在非糖尿病和糖尿病大鼠之间,未观察到视网膜血管对去氧肾上腺素的血管收缩差异。糖尿病大鼠视网膜神经血管对神经节烟碱受体激动剂1,1-二甲基-4-苯基哌嗪鎓的血管舒张反应也减弱。这些结果表明,糖尿病改变了视网膜对循环儿茶酚胺的血管反应,而β-肾上腺素受体介导的血管舒张反应的损害也是这种改变的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号